[Form 4] Septerna, Inc. Insider Trading Activity
Samira Shaikhly, identified as Chief People Officer of Septerna, Inc. (SEPN), acquired a derivative award disclosed on Form 4. The filing reports a grant of a stock option to purchase 30,000 shares of Septerna common stock with an exercise price of $11.70; the transaction date is 08/07/2025 and the Form 4 is signed on 08/11/2025.
The option is owned directly, the instrument lists an expiration date of 08/06/2035, and the grant vests in 1/48th of the shares monthly on each monthly anniversary of August 1, 2025, subject to continuous service. Following the transaction the reporting person beneficially owns 30,000 options.
- Grant of 30,000 stock options reported, providing clear disclosure of executive compensation
- Exercise price disclosed: $11.70 per share
- Detailed vesting schedule: 1/48th monthly installments beginning Aug 1, 2025, is specified
- Direct beneficial ownership: 30,000 options held directly following the transaction
- None.
Insights
TL;DR: Routine officer equity grant—30,000 options at $11.70 strike, monthly vesting over 48 months, long exercise window to 2035.
The Form 4 documents a standard executive equity award rather than an open-market transaction. Key facts: 30,000 options, $11.70 exercise price, acquisition date 08/07/2025, direct ownership and expiration on 08/06/2035. The monthly 1/48th vesting schedule ties compensation to continued service; the long expiration is typical for option grants. This disclosure is material as a compensation and governance item but appears routine for executive awards.
TL;DR: Governance disclosure shows officer-level grant with time-based vesting; standard signature by attorney-in-fact on Form 4.
The filing identifies the reporting person as an officer (Chief People Officer) and shows the option grant reported via Form 4, signed by an attorney-in-fact (Ran Xiao) on 08/11/2025. The explicit vesting language—1/48th monthly installments beginning Aug 1, 2025—and direct ownership of 30,000 options are clear governance items for stakeholders monitoring executive compensation. No other governance actions or departures are disclosed.